S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Closing prices for crude oil, gold and other commodities
How major US stock indexes fared Friday, 4/12/2024
5 Trends You Need to Know This Quarter
MarketBeat Week in Review – 4/8 - 4/12
Faced with possibly paying for news, Google removes links to California news sites for some users
The US and UK restrict the trade of Russian-origin metals
6 Things That Will Tell You If You Are Destined for Leadership
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Closing prices for crude oil, gold and other commodities
How major US stock indexes fared Friday, 4/12/2024
5 Trends You Need to Know This Quarter
MarketBeat Week in Review – 4/8 - 4/12
Faced with possibly paying for news, Google removes links to California news sites for some users
The US and UK restrict the trade of Russian-origin metals
6 Things That Will Tell You If You Are Destined for Leadership
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Closing prices for crude oil, gold and other commodities
How major US stock indexes fared Friday, 4/12/2024
5 Trends You Need to Know This Quarter
MarketBeat Week in Review – 4/8 - 4/12
Faced with possibly paying for news, Google removes links to California news sites for some users
The US and UK restrict the trade of Russian-origin metals
6 Things That Will Tell You If You Are Destined for Leadership
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Closing prices for crude oil, gold and other commodities
How major US stock indexes fared Friday, 4/12/2024
5 Trends You Need to Know This Quarter
MarketBeat Week in Review – 4/8 - 4/12
Faced with possibly paying for news, Google removes links to California news sites for some users
The US and UK restrict the trade of Russian-origin metals
6 Things That Will Tell You If You Are Destined for Leadership

Barinthus Biotherapeutics (BRNS) News Today

$3.14
-0.19 (-5.71%)
(As of 04/12/2024 ET)
SourceHeadline
finance.yahoo.com logoBarinthus Biotherapeutics Reports Significant Financial Shifts and Clinical Progress in 2023
finance.yahoo.com - March 22 at 5:53 PM
marketbeat.com logoWilliam Blair Comments on Barinthus Biotherapeutics plc's Q1 2025 Earnings (NASDAQ:BRNS)
marketbeat.com - March 22 at 8:35 AM
marketbeat.com logoBarinthus Biotherapeutics (NASDAQ:BRNS) Given New $8.00 Price Target at HC Wainwright
marketbeat.com - March 21 at 12:40 PM
benzinga.com logoBarinthus Biotherapeutics: Q4 Earnings Insights
benzinga.com - March 20 at 12:14 PM
globenewswire.com logoBarinthus Bio Reports Full Year 2023 Financial Results and Update on Corporate Developments
globenewswire.com - March 20 at 8:15 AM
finance.yahoo.com logoIndividual investors account for 48% of Barinthus Biotherapeutics plc's (NASDAQ:BRNS) ownership, while institutions account for 25%
finance.yahoo.com - March 4 at 10:58 AM
marketbeat.com logoBarinthus Biotherapeutics plc (NASDAQ:BRNS) Short Interest Update
marketbeat.com - February 29 at 7:44 AM
benzinga.com logoBarinthus Biotherapeutics Stock (NASDAQ:BRNS) Dividends: History, Yield and Dates
benzinga.com - February 25 at 10:37 AM
marketbeat.com logoBarinthus Biotherapeutics (NASDAQ:BRNS) Shares Up 3.1%
marketbeat.com - February 23 at 3:50 AM
marketbeat.com logoBarinthus Biotherapeutics plc to Post FY2023 Earnings of ($2.03) Per Share, HC Wainwright Forecasts (NASDAQ:BRNS)
marketbeat.com - January 10 at 7:26 AM
marketbeat.com logoBarinthus Biotherapeutics (NASDAQ:BRNS) Earns "Outperform" Rating from William Blair
marketbeat.com - January 8 at 8:16 AM
marketbeat.com logo
marketbeat.com - November 7 at 10:20 AM
Get Barinthus Biotherapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BRNS and its competitors with MarketBeat's FREE daily newsletter.

This consistently signaled gains of 453%... 610%... and even 1036%... (Ad)

It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.

Register for the imminent briefing here.

BRNS Media Mentions By Week

BRNS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BRNS
News Sentiment

1.44

0.63

Average
Medical
News Sentiment

BRNS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BRNS Articles
This Week

2

0

BRNS Articles
Average Week

Get Barinthus Biotherapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BRNS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:BRNS) was last updated on 4/13/2024 by MarketBeat.com Staff

From Our Partners